Concourse Financial Group Securities’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Concourse Financial Group Securities’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-89	Closed	-$795	–	2474
2021 Q4	$1K	Hold	89	–	–	﹤0.01%	2344
2021 Q3	$1K	Hold	89	–	–	﹤0.01%	2373
2021 Q2	$1K	Hold	89	–	–	﹤0.01%	2332
2021 Q1	$1K	Hold	89	–	–	﹤0.01%	2304
2020 Q4	$3K	Hold	89	–	–	﹤0.01%	2059
2020 Q3	$1K	Hold	89	–	–	﹤0.01%	2131
2020 Q2	$1K	Hold	89	–	–	﹤0.01%	2051
2020 Q1	$1K	Sell	89 -1	-1%	-$14	﹤0.01%	2122
2019 Q4	$2K	Hold	90	–	–	﹤0.01%	1947
2019 Q3	$1K	Hold	90	–	–	﹤0.01%	1709
2019 Q2	$1K	Hold	90	–	–	﹤0.01%	2162
2019 Q1	$1K	Hold	90	–	–	﹤0.01%	2207
2018 Q4	$1K	Buy	+90	New	+$1.58K	﹤0.01%	2070

Other funds holding LUMO

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Concourse Financial Group Securities's LUMO Position: Q1 2022 in Review

Concourse Financial Group Securities sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2022, closing a stake of 89 shares — an estimated $795 sold.

Concourse Financial Group Securities first reported a position in LUMO in Q4 2018 and held it in 13 quarters. The position peaked at $3K in Q4 2020. 36 funds tracked by Wall St. Rank hold LUMO as of Q1 2022.

Concourse Financial Group Securities reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Concourse Financial Group Securities sold 89 Lumos Pharma, Inc. Common Stock shares in Q1 2022, an estimated $795.
Concourse Financial Group Securities first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2018 and held it in 13 quarters.
Concourse Financial Group Securities's Lumos Pharma, Inc. Common Stock position peaked at $3K in Q4 2020.
36 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2022.

Based on Concourse Financial Group Securities's 13F filing for Q1 2022, filed 9 May 2022.